Radiomics: a potential biomarker for N2 malignancy in clinical stage I lung adenocarcinoma

Detalles Bibliográficos
Autores principales: Deng, Jiajun, She, Yunlang, Yang, Minglei, Zhang, Lei, Xie, Dong, Chen, Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481646/
https://www.ncbi.nlm.nih.gov/pubmed/32955508
http://dx.doi.org/10.21037/tlcr-20-683
_version_ 1783580650921525248
author Deng, Jiajun
She, Yunlang
Yang, Minglei
Zhang, Lei
Xie, Dong
Chen, Chang
author_facet Deng, Jiajun
She, Yunlang
Yang, Minglei
Zhang, Lei
Xie, Dong
Chen, Chang
author_sort Deng, Jiajun
collection PubMed
description
format Online
Article
Text
id pubmed-7481646
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-74816462020-09-17 Radiomics: a potential biomarker for N2 malignancy in clinical stage I lung adenocarcinoma Deng, Jiajun She, Yunlang Yang, Minglei Zhang, Lei Xie, Dong Chen, Chang Transl Lung Cancer Res Letter to the Editor AME Publishing Company 2020-08 /pmc/articles/PMC7481646/ /pubmed/32955508 http://dx.doi.org/10.21037/tlcr-20-683 Text en 2020 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Letter to the Editor
Deng, Jiajun
She, Yunlang
Yang, Minglei
Zhang, Lei
Xie, Dong
Chen, Chang
Radiomics: a potential biomarker for N2 malignancy in clinical stage I lung adenocarcinoma
title Radiomics: a potential biomarker for N2 malignancy in clinical stage I lung adenocarcinoma
title_full Radiomics: a potential biomarker for N2 malignancy in clinical stage I lung adenocarcinoma
title_fullStr Radiomics: a potential biomarker for N2 malignancy in clinical stage I lung adenocarcinoma
title_full_unstemmed Radiomics: a potential biomarker for N2 malignancy in clinical stage I lung adenocarcinoma
title_short Radiomics: a potential biomarker for N2 malignancy in clinical stage I lung adenocarcinoma
title_sort radiomics: a potential biomarker for n2 malignancy in clinical stage i lung adenocarcinoma
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481646/
https://www.ncbi.nlm.nih.gov/pubmed/32955508
http://dx.doi.org/10.21037/tlcr-20-683
work_keys_str_mv AT dengjiajun radiomicsapotentialbiomarkerforn2malignancyinclinicalstageilungadenocarcinoma
AT sheyunlang radiomicsapotentialbiomarkerforn2malignancyinclinicalstageilungadenocarcinoma
AT yangminglei radiomicsapotentialbiomarkerforn2malignancyinclinicalstageilungadenocarcinoma
AT zhanglei radiomicsapotentialbiomarkerforn2malignancyinclinicalstageilungadenocarcinoma
AT xiedong radiomicsapotentialbiomarkerforn2malignancyinclinicalstageilungadenocarcinoma
AT chenchang radiomicsapotentialbiomarkerforn2malignancyinclinicalstageilungadenocarcinoma

Ejemplares similares